The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.
FDA Drug Info has posted new Drug Safety Podcasts for Healthcare Professionals. Click on the following links to listen to podcasts and read the transcripts.
- Updated information about the risk of blood clots in women taking birth control pills containing drospirenone
- New Warning and Contraindication for blood pressure medicines containing aliskiren (Tekturna)
- Updated information on drug interactions between Victrelis (boceprevir) and certain boosted HIV protease inhibitor drugs